Results 251 to 260 of about 142,613 (313)

Impact of glucocorticoid receptor polymorphism rs6198 on sepsis survival in a prospective multicenter cohort. [PDF]

Sci Rep
Sombetzki C, Palmowski L, Ziehe D, Nowak H, Rahmel T, Ehrentraut SF, Thon P, Orlowski J, Bergmann L, Adamzik M, Koos B, Rump K, SepsisDataNet.NRW research group.   +12 more
europepmc   +1 more source

The human glucocorticoid receptor variant rs6190 increases blood cholesterol and promotes atherosclerosis. [PDF]

J Clin Invest
Durumutla HB, Haller A, Noble G, Prabakaran AD, McFarland K, Latimer H, Rajput A, Akinborewa O, Namjou-Khales B, Hui DY, Quattrocelli M.   +10 more
europepmc   +1 more source

Glucocorticoid receptors

Japanese Journal of Pharmacology, 1978
openaire   +1 more source

TENT5C functions as a corepressor in the ligand-bound glucocorticoid receptor and estrogen receptor α complexes. [PDF]

FEBS J
Li Y, Perera L, He RS, Baptissart M, Petrovich RM, Morgan M.   +5 more
europepmc   +1 more source

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome. [PDF]

Kidney Int Rep
van den Berge BT, Jansen J, Wetzels JFM, Smeets B, Maas RJ.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The human glucocorticoid receptor

2023
Glucocorticoids are members of steroid hormones that are biosynthesized in the intermediate cellular zone of the adrenal cortex (zona fasciculata) and released into the peripheral blood as final products of the hypothalamic-pituitary-adrenal (HPA) axis, as well as under the control of the circadian biologic system.
Nicolas C, Nicolaides, George P, Chrousos   +1 more
openaire   +2 more sources

Glucocorticoid receptor blockers

Pituitary, 2022
Mifepristone is the only glucocorticoid receptor antagonist currently approved for the treatment of Cushing's syndrome. Although originally developed as an abortifacient due to its blockade of the progesterone receptor, a number of case reports documented its efficacy as a glucocorticoid receptor blocker going back to 1985. The SEISMIC trial, published
openaire   +2 more sources